Long-Acting Cabotegravir and Rilpivirine: Innovation, New Challenges, and Opportunities

Clin Infect Dis. 2023 May 3;76(9):1655-1657. doi: 10.1093/cid/ciad024.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adult
  • HIV Infections* / drug therapy
  • HIV Infections* / virology
  • HIV-1*
  • Humans
  • Pyridones
  • Rilpivirine / therapeutic use

Substances

  • Rilpivirine
  • cabotegravir
  • Pyridones